US Patent 9585950 Capsular gram-positive bacteria bioconjugate vaccines
Patent 9585950 was granted and assigned to GlycoVaxyn on March, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9585950 Capsular gram-positive bacteria bioconjugate vaccines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
